Unknown

Dataset Information

0

Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers.


ABSTRACT: The search for experimental models mimicking an early stage of Parkinson's disease (PD) before motor manifestations is fundamental in order to explore early signs and get a better prognosis. Interestingly, our previous studies have indicated that 6-hydroxydopamine (6-OHDA) is a suitable model to induce an early degeneration of the nigrostriatal system without any gross motor impairment. Considering our previous findings, we aim to implement a novel system to monitor rats after intrastriatal injection of 6-OHDA to detect and analyze physiological changes underlying prodromal PD. Twenty male Sprague-Dawley rats were unilaterally injected with 6-OHDA (n = 10) or saline solution (n = 10) into the right striatum and placed in enriched environment cages where the activity was monitored. After 2 weeks, the amphetamine test was performed before the sacrifice. Immunohistochemistry was developed for the morphological evaluation and western blot analysis to assess molecular changes. Home-cage monitoring revealed behavioral changes in response to 6-OHDA administration including significant hyperactivity and hypoactivity during the light and dark phase, respectively, turning out in a change of the circadian timing. A preclinical stage of PD was functionally confirmed with the amphetamine test. Moreover, the loss of tyrosine hydroxylase expression was significantly correlated with the motor results, and 6-OHDA induced early proapoptotic events. Our findings provide evidence for a novel prodromal 6-OHDA model following a customized monitoring system that could give insights to detect non-motor deficits and molecular targets to test neuroprotective/neurorestorative agents.

SUBMITTER: Requejo C 

PROVIDER: S-EPMC7591774 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers.

Requejo Catalina C   López-de-Ipiña Karmele K   López-de-Ipiña Karmele K   Ruiz-Ortega José Ángel JÁ   Fernández Elsa E   Calvo Pilar M PM   Morera-Herreras Teresa T   Miguelez Cristina C   Cardona-Grifoll Laura L   Cepeda Hodei H   Ugedo Luisa L   Lafuente José Vicente JV  

Frontiers in neuroscience 20201014


The search for experimental models mimicking an early stage of Parkinson's disease (PD) before motor manifestations is fundamental in order to explore early signs and get a better prognosis. Interestingly, our previous studies have indicated that 6-hydroxydopamine (6-OHDA) is a suitable model to induce an early degeneration of the nigrostriatal system without any gross motor impairment. Considering our previous findings, we aim to implement a novel system to monitor rats after intrastriatal inje  ...[more]

Similar Datasets

| S-EPMC7780378 | biostudies-literature
| S-EPMC6316593 | biostudies-literature
| S-EPMC7136415 | biostudies-literature
| S-EPMC6315543 | biostudies-literature
| S-EPMC6729300 | biostudies-literature
| S-EPMC2658055 | biostudies-literature
| S-EPMC5722226 | biostudies-literature
| S-EPMC7891584 | biostudies-literature
| S-EPMC4242190 | biostudies-literature
| S-EPMC6584451 | biostudies-literature